Literature DB >> 31629446

Pheochromocytoma arising in the settingof adrenal-renal fusion.

Spyridon P Basourakos1, Lucas Dean, James Van Gurp, Victor Reuter, Paul Russo.   

Abstract

Adrenal-renal fusion is an anomaly misclassified as a renal tumor due to the absence of pathognomonic radiographic features. Herein, we report a case of a 61-year-old male who underwent a right radical nephrectomy for a presumed renal malignancy. Pathologic evaluation demonstrated a pheochromocytoma in the context of adrenal-renal fusion. Neoplastic transformation of fused adrenal tissue is rare but not unheard of and is typically adrenal cortical in origin. To our knowledge, this is the first description of a pheochromocytoma originating from an adrenal-renal fusion. The clinical presentation did not raise a high index of suspicion for the ultimate diagnosis rendered.

Entities:  

Mesh:

Year:  2019        PMID: 31629446      PMCID: PMC8785806     

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  4 in total

1.  Combined adrenorenal fusion and adrenohepatic adhesion: a case report with review of the literature and discussion of pathogenesis.

Authors:  L H Honoré; K E O'Hara
Journal:  J Urol       Date:  1976-03       Impact factor: 7.450

Review 2.  Adrenocortical Carcinoma Arising in an Adrenal Rest: a Case Report and Review of the Literature.

Authors:  Kristine M Cornejo; Henrietta A Afari; Peter M Sadow
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

3.  Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.

Authors:  Lester D R Thompson
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

4.  Pheochromocytoma in Urologic Practice.

Authors:  Nikhil Waingankar; Gennady Bratslavsky; Camilo Jimenez; Paul Russo; Alexander Kutikov
Journal:  Eur Urol Focus       Date:  2016-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.